Induction of Microsomal Enzymes by Foreign Chemicals and Carcinogenesis by Polycyclic Aromatic Hydrocarbons: G. H. A. Clowes Memorial Lecture

Cancer Research

Volumn 42, Issue 12, 1982, Pages 4875-4917

  Conney, Allan H ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CARCINOGEN; DRUG METABOLIZING ENZYME; INDUSTRIAL TOXIC SUBSTANCE; MICROSOME ENZYME; PHENOBARBITAL; POLYCYCLIC AROMATIC HYDROCARBON;

CARCINOGENESIS; CHEMICAL CARCINOGENESIS; DRUG EFFICACY; ENZYME INDUCTION; LIVER; NONHUMAN; REVIEW;

ANIMAL; CARCINOGENS; COOKERY; CYTOCHROME P-450 ENZYME SYSTEM; DIET; ENZYME INDUCTION; EPOXIDE HYDROLASES; HUMAN; KINETICS; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; POLYCYCLIC HYDROCARBONS; PORTRAITS; RATS; SMOKING;

EID: 0020431144     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (366)

1. Adesnik, M., Bar-Nun, S., Maschio, F., Zunich, M., Lippman, A., and Bard, E. Mechanism of induction of cytochrome P-450 by phenobarbital. J. Biol. Chem., 256: 10340–10345. 1981.
2. Alexanderson, B., Evans, D. A. P., and Sjoqvist, F. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br. Med. J., 4: 764–768, 1969.
3. Alvares, A. P., Anderson, K. E., Conney, A. H., and Kappas, A. Interactions between nutritional factors and drug biotransformations in man. Proc. Natl. Acad. Sci. U. S. A., 73: 2501–2504, 1976.
4. Alvares, A. P., Fischbein, A., Anderson, K. E., and Kappas, A. Alterations in drug metabolism in workers exposed to polychlorinated biphenyls. Clin. Pharmacol. Ther., 22: 140–146, 1977.
5. Alvares, A. P., Kappas, A., Eiseman, J. L., Anderson, K. E., Pantuck, C. B., Pantuck, E. J., Hsiao, K.-C., Garland, W. A., and Conney, A. H. Intraindividual variation in drug disposition. Clin. Pharmacol. Ther., 26: 407–419, 1979.
6. Alvares. A. P., Kappas, A., Levin, W., and Conney, A. H. Inducibility of benzo[a)pyrene hydroxylase in human skin by polycyclic hydrocarbons. Clin. Pharmacol. Ther., 14: 30–40, 1973.
7. Alvares, A. P., Schilling, G., Levin, W., and Kuntzman, R. Studies on the induction of CO-binding pigments in liver microsomes by phenobarbital and 3-methylcholanthrene. Biochem. Biophys. Res. Commun., 29: 521–526, 1967.
8. Alvares, A. P., Schilling, G., Levin, W., and Kuntzman, R. Alteration of the microsomal hemoprotein by 3-methylcholanthrene: effects of ethionine and actinomycin D. J. Pharmacol. Exp. Ther., 163: 417–424, 1968.
9. Amin, S., LaVoie, E. J., and Hecht, S. S. Identification of metabolites of benzo[b]fluoranthene. Carcinogenesis (Lond.), 3: 171–174, 1982.
10. Anderson, K., Conney, A. H., and Kappas, A. Nutrition and oxidative drug metabolism in man: relative influence of dietary lipids, carbohydrate, and protein. Clin. Pharmacol. Ther., 26: 493–501, 1979.
11. Autrup, H., Harris, C. C., Trump, B. F., and Jeffrey, A. M. Metabolism of benzo(a)pyrene and identification of the major benzo(a)pyrene-DNA adducts in cultured human colon. Cancer Res., 38: 3689–3696, 1978.
12. Axelrod. J. The enzymic cleavage of aromatic ethers. Biochem. J., 63: 634–639, 1956.
13. Axelrod, J. Possible mechanism of tolerance to narcotic drugs. Science (Wash. D. C.). 124: 263–264, 1956.
14. Baird, W. M., and Diamond, L. The nature of benzo(a)pyrene-DNA adducts formed in hamster embryo cells depends on the length of time of exposure to benzo(a)pyrene. Biochem. Biophys. Res. Commun., 77: 162–167, 1977.
15. Bast, R. C., Jr., Whitlock, J. P., Jr., Miller, H., Rapp, H. J., and Gelboin, H. V. Aryl hydrocarbon (benzo[a]pyrene) hydroxylase in human peripheral blood monocytes. Nature (Lond.), 250: 664–665, 1974.
16. Batzinger, R. P., Ou, S.-Y.L., and Bueding, E. Antimutagenic effects of 2(3Wert-butyl-4-hydroxyanisole and of antimicrobial agents. Cancer Res., 38: 4478–4485, 1978.
17. Benson, A. M., Batzinger. R. P., Ou, S.-Y.L., Bueding, E., Cha, Y.-N., and Talalay, P. Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res., 38: 4486–4495, 1978.
18. Bentley, P., Oesch, F., and Glatt, H. Dual role of epoxide hydratase in both activation and inactivation of benzo(a]pyrene. Arch. Toxicol., 39: 65–75, 1977.
19. Bhat, K. S., and Padmanaban, G. Studies on the biosynthesis of cytochrome P-450 in rat liver—a probe with phenobarbital. Arch. Biochem. Biophys., 198: 110–116, 1979.
20. Bigger, C. A. H., Tomaszewski, J. E., and Dipple, A. Differences between products of binding of 7,12-dimethylbenz(a]anthracene to DNA in mouse skin and in a rat liver microsomal system. Biochem. Biophys. Res. Commun., 80: 229–235, 1978.
21. Boger, E., O'Malley, R. F., and Sardella, D. J. Active sites in dibenzopyrenes: synthesis and studies of 3-fluoro- and 2,10-difluorobenzo(rsf]pentaphene. J. Fluorine Chem., 8: 513–525, 1976.
22. Bolt, H. M., Kappus, H., and Bolt, M. Effect of rifampicin treatment on the metabolism of oestradiol and 17a-ethinyloestradiol by human liver microsomes. Eur. J. Clin. Pharmacol., 8: 301–307, 1975.
23. Borgen, A., Darvey, H., Castagnoli, N., Crocker, T. T., Rasmussen, R. E., and Wang, I. Y. Metabolic conversion of benzo[a)pyrene by Syrian hamster liver microsomes and binding of metabolites to deoxyribonucleic acid. J. Med. Chem., 16: 502–506, 1973.
24. Botelho, L. H., Ryan, D. E., and Levin, W. Amino acid compositions and partial amino acid sequences of three highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinafed biphenyls, phenobarbital, or 3-methylcholanthrene. J. Biol. Chem., 254: 5635–5640, 1979.
25. Botelho, L. H., Ryan, D. E., Yuan, P.-M., Kutny, R., Shively, J. E., and Levin, W. Amino-terminal and carboxy-terminal sequence of hepatic microsomal cytochrome P-450d, a unique hemoprotein from rats treated with isosafrole. Biochemistry, 21: 1152–1155, 1982.
26. Boyland, E. The biological significance of metabolism of polycyclic compounds. Biochem. Soc. Symp., 5: 40–54, 1950.
27. Breckenridge, A., Back, D. J., Crawford, F. E., Maclver, M., Orme, M.L.E., Park, B. K., Rowe, P. H., and Smith, E. Drug interactions with contraceptive steroids. Symp. Med. Hoechst, 14: 607–613, 1979.
28. Breckenridge, A. M., Back, D. J., Cross, K., Crawford, F., Maclver, M., Orme, M. L. E., Rowe, P. H., and Smith, E. Influence of environmental chemicals on drug therapy in humans: studies with contraceptive steroids. In: D. Evered and G. Lawrenson (eds.), Environmental Chemicals, Enzyme Function and Human Disease, Ciba Foundation Symposium 76 (new series), pp. 289–306. Amsterdam: Excerpta Medica, 1980.
29. Bresnick, E., Brosseau, M., Levin, W., Reik, L., Ryan, D. E., and Thomas, P. E. Administration of 3-methylcholanthrene to rats increases the specific hybridizable mRNA coding for cytochrome P-450c. Proc. Natl. Acad. Sci. U. S. A., 78: 4083–4087, 1981.
30. Bresnick, E., McDonald, T. F., Yagi, H., Jerina, D. M., Levin, W., Wood, A. W., and Conney, A. H. Epidermal hyperplasia after topical application of benzo(a)pyrene, benzo(a)pyrene diol epoxides, and other metabolites. Cancer Res., 37: 984–990, 1977.
31. Brookes, P., and Lawley, P. D. Reaction of some mutagenic and carcinogenic compounds with nucleic acids. J. Cell Comp. Physiol., 64: 111-128, 1964.
32. Brookes, P., and Lawley, P. D. Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature (Lond.), 202: 781 -784, 1964.
33. Brooks, S. M., Werk, E., Ackerman, S. J., Sullivan, I., and Thrasher, K. Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma. N. Engl. J. Med., 286: 1125-1128, 1972.
34. Brown, H. S., Jeffrey. A. M., and Weinstein, I. B. Formation of DNA adducts in 10T1/2 mouse embryo fibroblasts incubated with benzo(a)pyrene or dihydrodiol oxide derivatives. Cancer Res., 39: 1673–1677, 1979.
35. Brown, R. R., Miller, J. A., and Miller, E. C. The metabolism of methylated aminoazo dyes. IV. Dietary factors enhancing demethylation in vitro. J. Biol. Chem., 209: 211–222, 1954.
36. Buening, M. K., Chang, R. L., Huang, M.-T., Fortner, J. G., Wood, A. W., and Conney, A. H. Activation and inhibition of benzo[a]pyrene and aflatoxin B, metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res., 41: 67–72, 1981.
37. Buening, M. K., Fortner, J. G., Kappas, A., and Conney, A. H. 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B, to mutagens by human liver. Biochem. Biophys. Res. Commun., 82: 348–355, 1978.
38. Buening, M. K., Levin, W., Karle, J. M., Yagi, H., Jerina, D. M., and Conney, A. H. Tumorigenicity of bay-region epoxides and other derivatives of chrysene and phenanthrene in newborn mice. Cancer Res., 39: 5063–5068, 1979.
39. Buening, M. K., Levin, W., Wood, A. W., Chang, R. L., Lehr, R. E., Taylor, C. W., Yagi, H., Jerina, D. M., and Conney, A. H. Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice. Cancer Res., 40: 203–206, 1980.
40. Buening, M. K., Levin, W., Wood, A. W., Chang, R. L., Yagi, H., Karle, J. M., Jerina, D. M., and Conney, A. H. Tumorigenicity of the dihydrodiols of dibenzo(a,h)anthracene on mouse skin and in newborn mice. Cancer Res., 39: 1310–1314, 1979.
41. Buening, M. K., Wislocki, P. G., Levin, W., Yagi, H., Thakker, D. R., Akagi, H., Koreeda, M., Jerina, D. M., and Conney, A. H. Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7β,8α-dihydroxy-9α.10α-epoxy-7,8,9,10-tetrahydrobenzo(a]pyrene. Proc. Natl. Acad. Sci. U. S. A., 75: 5358–5361, 1978.
42. Bums, J. J., Rose, R. K., Chenkin, T., Goldman, A., Schulert, A., and Brodie, B. B. The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J. Pharmacol. Exp. Ther., 109: 346–357, 1953.
43. Burstein, S., and Klaiber, E. L. Phenobarbital-induced increase in 6 β -hydroxycortisol excretion: clue to its significance in human urine. J. Clin. Endocrinol. Metab., 25: 293–296, 1965.
44. Busbee, D. L., Shaw, C. R., and Cantrell, E. T. Aryl hydrocarbon hydroxylase induction in human leukocytes. Science (Wash. D. C.), 178: 315-316. 1972.
45. Campbell, T. C. Nutrition and drug-metabolizing enzymes. Clin. Pharmacol. Ther., 22: 699–706, 1977.
46. Cavalieri, E., Roth, R., Althoff, J. Grandjean, C., Patil, K., Marsh, S., and McLaughlin, D. Carcinogenicity and metabolic profiles of 3-methylcholanthrene oxygenated derivatives at the 1 and 2 positions. Chem.-Biol. Interact., 22: 69–81, 1978.
47. Cerutti, P. A., Sessions, F., Hariharan, P. V., and Lusby, A. Repair of DNA damage induced by benzo(a)pyrene diol-epoxides I and II in human alveolar tumor cells. Cancer Res., 38: 2118–2124, 1978.
48. Cha, Y.-N., and Bueding, E. Effect of 2(3)-terf-butyl-4-hydroxyanisole administration on the activities of several hepatic microsomal and cytoplasmic enzymes in mice. Biochem. Pharmacol., 28: 1917–1921, 1979.
49. Cha, Y.-N., Martz, F., and Bueding, E. Enhancement of liver microsome epoxide hydratase activity in rodents by treatment with 2(3)-tert-butyl-4-hydroxyanisole. Cancer Res., 38: 4496–4498, 1978.
50. Chang, R. L., Levin, W., Wood, A. W., Lehr, R. E., Kumar, S., Yagi, H., Jerina, D. M., and Conney, A. H. Tumorigenicity of the diastereomeric bay-region benzo(e)pyrene 9,10-diol-11,12-epoxides in newborn mice. Cancer Res., 41: 915–918, 1981.
51. Chang, R. L., Levin, W., Wood, A. W., Lehr, R. E., Kumar, S., Yagi, H., Jerina, D. M., and Conney, A. H. Tumorigenicity of bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo-(a,i)pyrene on mouse skin and in newborn mice. Cancer Res., 42: 25–29, 1982.
52. Chang, R. L., Levin, W., Wood, A. W., Yagi, H., Tada, M., Vyas, K. P., Jerina, D. M., and Conney, A. H. Tumorigenicity of enantiomers of chrysene 1, 2-dihydrodiol and of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides on mouse skin and in newborn mice. Cancer Res., 43: in press, 1983.
53. Chang, R. L., Wislocki, P. G., Kapitulnik, J., Wood, A. W., Levin, W., Yagi, H., Mah, H. D., Jerina, D. M., and Conney, A. H. Carcinogenicity of 2-hydroxybenzo(a)pyrene and 6-hydroxybenzo(a)pyrene in newborn mice. Cancer Res., 39: 2660–2664, 1979.
54. Chang, R. L., Wood, A. W., Levin, W., Mah, H. D., Thakker, D. R., Jerina, D. M., and Conney, A. H. Differences in mutagenicity and cytotoxicity of (+)- and (-)-benzo(a)pyrene 4,5-oxide: a synergistic interaction of enantiomers. Proc. Natl. Acad. Sci. U. S. A., 76: 4280–4284, 1979.
55. Chouroulinkov, I. Gentil, A., Grover, P. L., and Sims, P. Tumor-initiating activities on mouse skin of dihydrodiols derived from benzo[a]pyrene. Br. J. Cancer, 34: 523–532, 1976.
56. Chouroulinkov, I., Gentil, A., Tierney, B., Grover, P., and Sims, P. The metabolic activation of 7-methylbenz(a)anthracene in mouse skin: high tumor-initiating activity of the 3,4-dihydrodiol. Cancer Lett., 3: 247–253, 1977.
57. Chouroulinkov, I., Gentil, A., Tierney, B., Grover, P. L., and Sims, P. The initiation of tumours on mouse skin by dihydrodiols derived from 7,12-dimethylbenz(a)anthracene and 3-methyicholanthrene. Int. J. Cancer, 24: 455–460, 1979.
58. Colbert, R. A., Bresnick, E., Levin, W., Ryan, D. E., and Thomas, P. E. Synthesis of liver cytochrome P-450b in a cell-free protein synthesizing system. Biochem. Biophys. Res. Commun., 91: 886–891, 1979.
59. Conney, A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev., 19: 317–366, 1967.
60. Conney, A. H. Microsomes and drug oxidations: perspectives and challenges. In: M. J. Coon, A. H. Conney, R. W. Estabrook, H. V. Gelboin, J. R. Gillette, and P. J. O. Brien (eds.), Microsomes, Drug Oxidations and Chemical Carcinogenesis, Vol. 2, pp. 1103–1118. New York: Academic Press. Inc., 1980.
61. Conney, A. H., Brown, R. R., Miller, J. A., and Miller, E. C. The metabolism of methylated aminoazo dyes. VI. Intracellular distribution and properties of the demethylase system. Cancer Res., 17: 628–633, 1957.
62. Conney, A. H., and Bums, J. J. Stimulatory effect of foreign compounds on ascorbic acid biosynthesis and on drug-metabolizing enzymes. Nature (Lond.), 184: 363–364, 1959.
63. Conney, A. H., and Burns, J. J. Physiological disposition and metabolic fate of chlorzoxazone (Paraflex) in man. J. Pharmacol. Exp. Ther., 128: 340–343, 1960.
64. Conney, A. H., and Burns, J. J. Metabolic interactions among environmental chemicals and drugs. Science (Wash. D. C.), 178: 576–586, 1972.
65. Conney, A. H., Davison, C., Gastel, R., and Bums, J. J. Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs. J. Pharmacol. Exp. Ther., 130: 1-8, 1960.
66. Conney, A. H., and Gelboin, H. V. Antagonism and potentiation of drug action and the mechanism of microsomal enzyme induction. In: L. Meyler and H. M. Peck (eds.), Drug Induced Diseases, Vol. 4, pp. 179–207. Amsterdam: Excerpta Medica. 1972.
67. Conney, A. H., Gillette. J. R., Inscoe, J. K., Trams, E. R., and Posner, H. S. Induced synthesis of liver microsomal enzymes which metabolize foreign compounds. Science (Wash. D. C.), 130: 1478–1479, 1959.
68. Conney, A. H., Jacobson, M., Levin, W., Schneidman, K., and Kuntzman, R. Decreased central depressant effect of progesterone and other steroids in rats pretreated with drugs and insecticides. J. Pharmacol. Exp. Ther., 154: 310–318, 1966.
69. Conney, A. H., Jacobson, M., Schneidman, K., and Kuntzman, R. Induction of liver microsomal cortisol 6β-hydroxylase by diphenylhydantoin or phenobarbital: an explanation for the increased excretion of 6-hydroxycortisol in humans treated with these drugs. Life Sci., 4: 1091–1098, 1965.
70. Conney, A. H., and Klutch, A. Increased activity of androgen hydroxylases in liver microsomes of rats pretreated with phenobarbital and other drugs. J. Biol. Chem., 238: 1611-1617, 1963.
71. Conney, A. H., and Kuntzman, R. Metabolism of normal body constituents by drug-metabolizing enzymes in liver microsomes. In: B. B. Brodie and J. Gillette (eds.), Concepts in Biochemical Pharmacology, Handbook of Experimental Pharmacology Series, pp. 401–421. Berlin: Springer-Verlag, 1971.
72. Conney, A. H., Levin, W., Ikeda, M., Kuntzman, R., Cooper, D. Y., and Rosenthal, O. Inhibitory effect of carbon monoxide on the hydroxylation of testosterone by rat liver microsomes. J. Biol. Chem., 243: 3912–3915, 1968.
73. Conney, A. H., Levin, W., Jacobson, M., and Kuntzman, R. Effects of drugs and environmental chemicals on steroid metabolism. Proceedings of the Symposium on Drugs and the Unborn Child, New York, 1973. Clin. Pharmacol. Ther., 14: 727–741, 1973.
74. Conney, A. H., Levin, W., Jacobson, M., Kuntzman, R., Cooper, D. Y., and Rosenthal, O. Specificity in the regulation of the 6β-, 7α- and 16α-hydroxylation of testosterone by rat liver microsomes. In: J. R. Gillette, A. H. Conney, G. J. Cosmides, R. W. Estabrook, J. R. Fouts, and G. J. Mannering (eds.), Microsomes and Drug Oxidations, pp. 279–302. New York: Academic Press, Inc., 1969.
75. Conney, A. H., Levin, W., Wood, A. W., Yagi, H., Lehr, R. E., and Jerina, D. M. Biological activity of polycyclic hydrocarbon metabolites and the bay region theory. Advances in Pharmacology and Therapeutics, Vol. 9, pp. 41–52. New York: Pergamon Press, 1978.
76. Conney, A. H., Levin, W., Wood, A. W., Yagi, H., Thakker, D. R., Lehr, R. E., and Jerina, D. M. Metabolism of polycyclic aromatic hydrocarbons to reactive intermediates with high biological activity. In: F. Coulston and P. Shubik (eds.), Human Epidemiology and Animal Laboratory Correlations in Chemical Carcinogenesis, pp. 153–183. Norwood, N. J.: Ablex Publishing Corporation, 1980.
77. Conney, A. H., Lu, A. Y. H., Levin, W., Somogyi, A., West, S., Jacobson, M., Ryan, D., and Kuntzman, R. Effect of enzyme inducers on substrate specificity of the cytochrome P-450s. Proceedings of the Second International Symposium on Microsomes and Drug Oxidations, Palo Alto, California, 1972. Drug Metab. Dispos., 1: 199–210, 1973.
78. Conney, A. H., Miller, E. C., and Miller, J. A. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res., 16: 450–459, 1956.
79. Conney, A. H., Miller, E. C., and Miller, J. A. Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J. Biol. Chem., 228: 753–766, 1957.
80. Conney, A. H., Pantuck, E. J., Hsiao, K.-C., Garland, W. A., Anderson, K. E., Alvares, A. P., and Kappas, A. Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clin. Pharmacol. Ther., 20: 633–642, 1976.
81. Conney, A. H., Pantuck, E. J., Pantuck, C. B., Buening, M., Jerina, D. M., Fortner, J. G., Alvares, A. P., Anderson, K. E., and Kappas, A. Role of environment and diet in the regulation of human drug metabolism. In: R. W. Estabrook and E. Lindenlaub (eds.). The Induction of Drug Metabolism, pp. 583–605. New York: F. K. Schattauer Verlag, 1979.
82. Conney, A. H., Pantuck, E. J., Pantuck, C. B., Fortner, J. G., Alvares, A. P., Anderson, K. E., and Kappas, A. Variability in human drug metabolism. In: P. Turner (ed.), Clinical Pharmacology and Therapeutics, pp. 51–62. London: Macmillan Publishers Ltd., 1980.
83. Conney, A. H., Sansur, M., Soroko, F., Koster, R., and Burns, J. J. Enzyme induction and inhibition in studies on the pharmacological actions of acetophenetidin. J. Pharmacol. Exp. Ther., 151: 133–138, 1966.
84. Conney, A. H., Trousof, N., and Burns, J. J. The metabolic fate of zoxazolamine (Flexin) in man. J. Pharmacol. Exp. Ther., 128: 333–339, 1960.
85. Conney, A. H., Welch, R., Kuntzman. R., Chang, R., Jacobson, M., Munro-Faure, A. D., Peck, A. W., Bye, A., Poland, A., Poppers, P. J., Finster, M., and Wolff, J. A. Effects of environmental chemicals on the metabolism of drugs, carcinogens and normal body constituents in man. Ann. N. Y. Acad. Sci., 179: 155–172, 1971.
86. Conney, A. H., Wood, A. W., Levin, W., Lu, A. Y. H., Chang, R. L., Wislocki, P. G., Goode, R. L., Holder, G. M., Dansette, P. M., Yagi, H., and Jerina, D. M. Metabolism and biological activity of benzo[a]pyrene and its metabolic products. In: D. Jollow, J. Kocsis, R. Snyder, and H. Vainio (eds.), Biological Reactive Intermediates, pp. 335–356. New York: Plenum Publishing Corporation, 1977.
87. Coombs, M. M., and Bhatt, T. S. High skin tumour initiating activity of the metabolically derived trans-3,4-dihydro-3,4-diol of the carcinogen 15.16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Carcinogenesis 3: 449–451, 1982.
88. Coombs, M. M., Kissonerghis, A.-M., Allen, J. A., and Vose, C. W. Identification of the proximate and ultimate forms of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Cancer Res., 39: 4160–4165, 1979.
89. Coon, M. J. The 1980 Bernard B. Brodie Award Lecture. Drug metabolism by cytochrome P-450: progress and perspectives. Drug Metab. Dispos., 9: 1–4, 1981.
90. Cooper, C. S., Ribeiro, O., Hewer, A., Walsh, C., Pal, K., Grover, P. L., and Sims, P. The involvement of a bay-region. and a non- ‘bay-region. diol-epoxide in the metabolic activation of benz[a]anthracene in mouse skin and in hamster embryo cells. Carcinogenesis (Lond.), 1: 233–243, 1980.
91. Cooper, C. S., Vigny, P., Kindts, M., Grover, P. L., and Sims, P. Metabolic activation of 3-methylcholanthrene in mouse skin: fluorescence spectral evidence indicates the involvement of diol-epoxides formed in the 7,8,9,10-ring. Carcinogenesis (Lond.), 1: 855–860, 1980.
92. Cooper, D. Y., Levin, S., Narasimhulu, S., Rosenthal, O., and Estabrook, R. W. Photochemical action spectrum of the terminal oxidase of mixed function oxidase systems. Science (Wash. D. C.), 147: 400–402, 1965.
93. Crosby, D. G. Natural toxic background in the food of man and his animals. J. Agr. Food Chem., 17: 532–538, 1969.
94. Cucinell, S. A., Conney, A. H., Sansur, M., and Burns, J. J. Drug interactions in man: I. Lowering effect of phenobarbital on plasma levels of bishydroxycoumarin (Dicumarol) and diphenylhydantoin (Dilantin). Clin. Pharmacol. Ther., 6: 420–429, 1965.
95. Daly, J. W., Jerina, D. M., and Witkop, B. Arene oxides and the NIH shift. The metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia (Basel), 28: 1129–1164, 1972.
96. Della Porta, G., and Terracini, B. Chemical carcinogenesis in infant animals. In: F. Homburger (ed.), Progress in Experimental Tumor Research, pp. 334–363. Basel: S. Karger AG, 1969.
97. Deutsch, J., Leutz, J., Yang, S. K., Gelboin, H. V., Chiang, Y. L., Vatsis, K. P., and Coon, M. J. Regio- and stereoselectivity of various forms of purified cytochrome P-450 in the metabolism of benzo[a]pyrene and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene as shown by product formation and binding to DNA. Proc. Natl. Acad. Sci. U. S. A., 75: 3123–3127, 1978.
98. Deutsch, J., Vatsis, K. P., Coon, M. J., Leutz, J. C., and Gelboin, H. V. Catalytic activity and stereoselectivity of purified forms of rabbit liver microsomal cytochrome P-450 in the oxygenation of the (-) and (+) enantiomers of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Mol. Pharmacol., 16: 1011–1018, 1979.
99. DiGiovanni, J., Diamond, L., Singer, J. M., Daniel, F. B., Witiak, D. T., and Slaga, T. J. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3.4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice. Carcinogenesis (Lond.), 3: 651–655, 1982.
100. Dipple, A., and Nebzydoski, J. A. Evidence for the involvement of a diol-epoxide in the binding of 7,12-dimethylbenz[a]anthracene to DNA in cells in culture. Chem.-Biol. Interact., 20: 17–26, 1978.
101. DuBois, R. N., and Waterman, M. R. Effect of phenobarbital administration to rats on the level of the in vitro synthesis of cytochrome P-450 directed by total rat liver RNA. Biochem. Biophys. Res. Commun., 90: 150–157, 1979.
102. Duvaldestin, P., Mazze, R. I., Nivoche, Y., and Desmonts, J.-M. Occupational exposure to Halothane results in enzyme induction in anesthetists. Anesthesiology, 54: 57–60, 1981.
103. Elshourbagy, N. A., and Guzelian, P. S. Separation, purification, and characterization of a novel form of hepatic cytochrome P-450 from rats treated with pregnenolone- 16α-carbonitrile. J. Biol. Chem., 255: 1279–1285, 1980.
104. Feldman, C. H., Hutchinson, V. E., Pippenger, C. E., Blumenfeld, T. A., Feldman, B. R., and Davis, W. J. Effect of dietary protein and carbohydrate on theophylline metabolism in children. Pediatrics, 66: 956–962, 1980.
105. Fisher, G. J., Fukushima, H., and Gaylor, J. L. Isolation, purification, and properties of a unique form of cytochrome P-450 in microsomes of isosaf-role-treated rats. J. Biol. Chem., 256: 4388–4394, 1981.
106. Fujii-Kuriyama, Y., Mizukami, Y., Kawajiri, K., Sogawa, K., and Muramatsu, M. Primary structure of a cytochrome P-450: coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver. Proc. Natl. Acad. Sci. U. S. A., 79: 2793–2797, 1982.
107. Fujii-Kuriyama, Y., Taniguch, T., Mizukami, Y., Sakai, M., Tashiro, Y., and Muramatsu, M. Molecular cloning of a complementary DNA of phenobarbital-inducible cytochrome P-450 messenger RNA from the rat. Proc. Jpn. Acad., 56: 603–608, 1980.
108. Garfinkel, D. Studies on pig liver microsomes, I. Enzymic and pigment composition of different microsomal fractions. Arch. Biochem. Biophys., 77: 493–509, 1958.
109. Garner, R. C., and McLean, A. E. M. Increased susceptibility to carbon tetrachloride poisoning in the rat after pretreatment with oral phenobarbitone. Biochem. Pharmacol., 18: 645–650, 1969.
110. Gelboin, H. V. A microsome-dependent binding of benzo[a]pyrene to DNA. Cancer Res., 29: 1272–1276, 1969.
111. Gibson, G. G., Orton, T. C., and Tamburini, P. P. Cytochrome P-450 induction by clofibrate: Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). Biochem. J., 203: 161–168, 1982.
112. Grover, P. L., and Sims, P. Enzyme-catalysed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. Biochem. J., 110: 159–160, 1968.
113. Guengerich, F. P. Separation and purification of multiple forms of microsomal cytochrome P-450. Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital- and 3-methylcholanthrene-treated rats. J. Biol. Chem., 253: 7931-7939, 1978.
114. Guzelian, P. S., Vranian, G., Boylan, J. J., Cohn, W. J., and Blanke, R.V. Liver structure and function in patients poisoned with chlordecone (Ke-pone). Gastroenterology, 78: 206–213, 1980.
115. Hammer, W., Idestrom, C.-M., and Sjoqvist, F. Chemical control of antidepressant drug therapy. In: S. Garattini and M. N. G. Dukes (ed.). International Congress Series, No. 122, Proceedings of the First International Symposium on Antidepressant Drugs, pp. 301–310. Amsterdam: Excerpta Medica, 1967.
116. Hansson, R., and Wikvall, K. Hydroxylations in biosynthesis and metabolism of bile acids. Catalytic properties of different forms of cytochrome P-450. J. Biol. Chem., 255: 1643–1649, 1980.
117. Harman, A. W., Frewin, D. B., and Priestly, B. G. Induction of microsomal drug metabolism in man and in the rat by exposure to petroleum. Br. J. Ind. Med., 38: 91–97, 1981.
118. Harman, A. W., Russell, W. J., Frewin, D. B., and Priestly, B. G. Altered drug metabolism in anaesthetists exposed to volatile anaesthetic agents. Anaesth. Intensive Care, 6: 210–214, 1978.
119. Harris, C. C., Trump, B. F., Grafstrom, R., and Autrup, H. Differences in the metabolism of chemical carcinogens in cultured human epithelial tissues and cells. In: C. C. Harris and P. Cerutti (eds.), Mechanisms of Chemical Carcinogenesis, pp. 289–298. New York: Alan R. Liss, Inc., 1982.
120. Harrison, Y. E., and West, W. L. Stimulatory effect of charcoal-broiled ground beef on the hydroxylation of 3,4-benzpyrene by enzymes in rat liver and placenta. Biochem. Pharmacol., 20: 2105–2108, 1971.
121. Hart, P., Farrell, G. C., Cooksley, W. G. E., and Powell, L. W. Enhanced drug metabolism in cigarette smokers. Br. Med. J., 2: 147–149, 1976.
122. Harvey, R. G. Carcinogenic hydrocarbons: metabolic activation and the mechanism of cancer induction. In: D. B. Walters (ed.), Safe Handling of Chemical Carcinogens, Mutagens, Teratogens and Highly Toxic Substances, Vol. 2, pp. 439–468. Ann Arbor, Mich.: Ann Arbor Science Publishers, Inc., 1980.
123. Hayes, J. R., and Campbell, T. C. Nutrition as a modifier of chemical carcinogenesis. In: T. J. Slaga (ed.), Carcinogenesis, Vol. 5, pp. 207–241. New York: Raven Press, 1980.
124. Hecht, S. S., Hirota, N., Loy, M., and Hoffmann, D. Tumor-initiating activity of fluorinated 5-methylchrysenes. Cancer Res., 38: 1694–1698, 1978.
125. Hecht, S. S., LaVoie, E. J., Bedenko, V., Pingaro, L., Katayama, S., Hoffmann, D., Sardella, D. J., Boger, E., and Lehr, R. E. Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo(a,i)pyrene. Cancer Res., 41: 4341-4345, 1981.
126. Hecht, S. S., LaVoie, E., Mazzarese, R., Amin, S., Bedenko, V., and Hoffmann, D. 1,2-Dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene. Cancer Res., 38: 2191–2194, 1978.
127. Hecht, S. S., LaVoie, E., Mazzarese, R., Hirota, N., Ohmori, T., and Hoffmann, D. Comparative mutagenicity, tumor initiating activity, carcinogenicity, and in vitro metabolism of fluorinated 5-methylchrysenes. J. Natl. Cancer Inst., 63: 855–861, 1979.
128. Hecht, S. S., Rivenson. A., and Hoffmann, D. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene. Cancer Res., 40. 1396–1399, 1980.
129. Heidelberger, C. Chemical carcinogenesis, chemotherapy: cancer's continuing core challenges—G. H. A. Clowes Memorial Lecture. Cancer Res. 30: 1549–1569, 1970.
130. Heuman, D. M., Gallagher, E. J., Barwick, J. L., Elshourbagy, N. A., and Guzelian, P. S. Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16α-carbonitrile or other steroidal or non-steroidal agents. Mol. Pharmacol., 21: 753–760, 1982.
131. Holder, G., Yagi, H., Dansette, P., Jerina, D. M., Levin, W., Lu, A. Y. H., and Conney, A. H. Effects of inducers and epoxide hydrase on the metabolism of benzo[a]pyrene by liver microsomes and a reconstituted system: analysis by high pressure liquid chromatography. Proc. Natl. Acad. Sci. U. S. A., 71: 4356–4360, 1974.
132. Holder, G. M., Yagi, H., Jerina, D. M., Levin, W., Lu, A. Y. H., and Conney, A. H. Metabolism of benzo[a]pyrene. II. Effect of substrate concentration and 3-methylcholanthrene pretreatment on hepatic metabolism by microsomes from rats and mice. Arch. Biochem. Biophys., 170: 557-566, 1975.
133. Huang, M.-T., Chang, R. L., Fortner, J. G., and Conney, A. H. Studies on the mechanism of activation of microsomal benzo[a]pyrene hydroxylation by flavonoids. J. Biol. Chem., 256: 6829–6836, 1981.
134. Huang, M.-T., Johnson, E. F., Muller-Eberhard, U., Koop, D. R., Coon, M. J., and Conney, A. H. Specificity in the activation and inhibition by flavonoids of benzo[a]pyrene hydroxylation by cytochrome P-450 isozymes from rabbit liver microsomes, J. Biol. Chem., 256: 10897–10901, 1981.
135. Huberman, E. Sachs, L., Yang, S. K., and Getboin, H. V. Identification of mutagenic metabolites of benzo[a]pyrene in mammalian cells. Proc. Natl. Acad. Sci. U. S. A., 73: 607–611, 1976.
136. Huggins, C., and Pataki, J. Aromatic azo derivatives preventing mammary cancer and adrenal injury from 7.12-dimethylbenz[a]anthracene. Proc. Natl. Acad. Sci. U. S. A., 53: 791–796, 1965.
137. Hunter, J. O., and Davie, M. Vitamin D metabolism in patients treated with phenytoin and phenobarbitone. In: D. Evered and G. Lawrenson (eds.), Environmental Chemicals, Enzyme Function and Human Disease, Ciba Foundation Symposium 76 (new series), pp. 315–330. Amsterdam: Excerpta Medica, 1980.
138. Ikeda, M., Conney, A. H., and Burns, J. J. Stimulatory effect of phenobarbital and insecticides on warfarin metabolism in the rat. J. Pharmacol. Exp. Ther., 162: 338–343, 1968.
139. Ivanovic, V., Geacintov, N. E., Jeffrey, A. M., Fu, P. P., Harvey, R. G., and Weinstein, I. B. Cell and microsome mediated binding of 7,12-dimethylbenzjajanthracene to DNA studied by fluorescence spectroscopy. Cancer Lett., 4: 131–140, 1978.
140. Ivanovic, V. Geacintov, N. E., Yamasaki, H., and Weinstein, I. B. DNA and RNA adducts formed in hamster embryo cell cultures exposed to benzo-[a]pyrene. Biochemistry, 17: 1597–1603, 1978.
141. Jacobson, M., Levin, W., Poppers, P. J., Wood, A. W., and Conney, A. H. Comparison of the O-dealkylation of 7-ethoxycoumarin and the hydroxylation of benzo[a]pyrene in human placenta: effect of cigarette smoking. Clin. Pharmacol. Ther., 16: 701–710, 1974.
142. Jeffrey, A. M., Jennette, K. W., Blobstein, S. H., Weinstein, I. B., Beland, F. A., Harvey, R. G., Kasai, H., Miura, I., and Nakanishi, K. Benzo[a]pyrene-nucleic acid derivative found in vivo: structure of a benzo[a]pyrenetetra-hydrodiol epoxide-guanosine adduct. J. Am. Chem. Soc., 98: 5714–5715, 1976.
143. Jeffrey, A. M., Weinstein, I. B., Jennette, K. W., Grzeskowiak, K., and Nakanishi, K. Structures of benzo[a]pyrene-nucleic acid adducts formed in human and bovine bronchial explants. Nature (Lond.), 269: 348–350, 1977.
144. Jenne, J., Nagasawa, H., McHugh. R., MacDonald, F., and Wyse, E. Decreased theophylline half-life in cigarette smokers. Life Sci., 17: 195–198, 1975.
145. Jerina, D. M., and Daly, J. W. Arene oxides: a new aspect of drug metabolism. Metabolic formation of arene oxides explains many toxic and carcinogenic properties of aromatic hydrocarbons. Science (Wash. D. C.), 185: 573–582, 1974.
146. Jerina, D. M., and Daly, J. W. Oxidation at carbon. In: D. V. Parke and R. L. Smith (eds.). Drug Metabolism—From Microbe to Man, pp. 13–32. London: Taylor and Francis, 1977.
147. Jerina, D. M., Daly, J. W., Witkop, B., Zaltzman-Nirenberg, P., and Uden-friend, S. The role of the arene oxide-oxepin systems in the metabolism of aromatic substrates. III. Formation of 1,2-naphthalene oxide from naphthalene by liver microsomes, J. Am. Chem. Soc., 90: 6525–6527, 1968.
148. Jerina, D. M., Daly, J. W., Witkop, B., Zaltzman-Nirenberg, P., and Uden-friend, S. 1.2-Naphthalene oxide as an intermediate in the microsomal hydroxylation of naphthalene. Biochemistry, 9: 147–156, 1970.
149. Jerina, D. M., Lehr, R. E., Yagi, H., Hernandez, O., Dansette, P. M., Wislocki, P. G., Wood, A. W., Chang, R. L., Levin, W., and Conney, A. H. Mutagenicity of benzo[a]pyrene derivatives and the description of a quantum mechanical model which predicts the ease of carbonium ion formation from diol epoxides. In: F. J. de Serres, J. R. Fouts, J. R. Bend, and R. M. Philpot (eds.), In Vitro Metabolic Activation in Mutagenesis Testing, pp. 159–178. Amsterdam: Elsevier/North Holland Biomedical Press, 1976.
150. Jerina, D. M., Sayer, J. M., Yagi, H., Croisy-Delcey, M., Ittah, Y., Thakker, D. R., Wood. A. W., Chang, R. L., Levin, W., and Conney, A. H. Highly tumorigenic bay-region diol epoxides from the weak carcinogen benzo-[c]phenanthrene. In: R. Snyder, D. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, and C. Witmer (eds.), Biological Reactive Intermediates—II, Part A, pp. 501-523. New York: Plenum Publishing Corporation, 1982.
151. Jerina, D. M., Yagi, H., Thakker, D. R., Karle, J. M., Mah, H. D., Boyd, D. R., Gadaginamath, G., Wood, A. W., Buening, M., Chang, R. L., Levin, W., and Conney, A. H. Stereoselective metabolic activation of polycyclic aromatic hydrocarbons. In: Y. Cohen (ed.). Advances in Pharmacology and Therapeutics. Vol. 9, pp. 53–62. New York: Pergamon Press, 1979.
152. Jusko, W. J., Schentag, J. J., Clark, J. H., Gardner, M., and Yurchak, A. M. Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clin. Pharmacol. Ther., 24: 406–410, 1978.
153. Kapitulnik, J., Levin, W., Conney, A. H., Yagi, H., and Jerina, D.M. Benzo-[a]pyrene 7,8-dihydrodiol is more carcinogenic than benzo[a]pyrene in newborn mice. Nature (Lond.), 266: 378–380, 1977.
154. Kapitulnik, J., Levin, W., Poppers, P. J., Tomaszewski, J. E., Jerina, D. M., and Conney, A. H. Comparison of the hydroxylation of zoxazolamine and benzo[a]pyrene in human placenta: effect of cigarette smoking. Clin. Pharmacol. Ther., 20: 557–564, 1976.
155. Kapitulnik, J., Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H. Lack of carcinogenicity of 4-, 5-, 6-, 7-, 8-, 9- and 10-hydroxybenzo[a]pyrene on mouse skin. Cancer Res., 36: 3625–3628, 1976.
156. Kapitulnik, J., Poppers, P. J., Buening, M. K., Fortner, J. G., and Conney, A. H. Activation of monooxygenases in human liver by 7,8-benzoflavone. Clin. Pharmacol. Ther., 22: 475–485, 1977.
157. Kapitulnik, J., Wislocki, P. G. Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H. Tumorigenicity studies with diol-epoxides of benzo[a]pyrene which indicate that (±)-trans-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzofajpyrene is an ultimate carcinogen in newborn mice. Cancer Res., 38: 354–358, 1978.
158. Kapitulnik, J., Wislocki, P. G., Levin, W., Yagi, H., Thakker, D. R., Akagi, H., Koreeda, M., Jerina, D. M., and Conney, A. H. Marked differences in the carcinogenic activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene in newborn mice. Cancer Res., 38: 2661–2665, 1978.
159. Kappas, A., Alvares, A. P., Anderson, K. E., Pantuck, E. J., Pantuck, C. B., Chang, R., and Conney, A. H. Effect of charcoal-broiled beef on antipyrine and theophylline metabolism. Clin. Pharmacol. Ther., 23: 445–450, 1978.
160. Kappas, A., Anderson, K. E., Conney, A. H., and Alvares, A. P. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin. Pharmacol. Ther., 20: 643–653, 1976.
161. Kato, R. Modificato quadro farmacologico di alcuni farmaci in animali pretrattati—48 ore prima—conaltri farmaci. Atti Soc. Lombarda Sc. Med-Biol., 14: 783–786, 1959.
162. Kato, R. Modifications of the toxicity of strychnine and octomethylpyrophosphoramide (OMPA) induced by pretreatment with phenaglycodol and thiopental. Arzneim-Forsch., 11: 797–798, 1961.
163. Kato, R., Chiesara, E., and Frontino, G. Induction of hepatic carisoprodol-metabolizing enzyme by pretreatment with some neuropsychotropic drugs in rats. Jpn. J. Pharmacol., 11: 31–36, 1961.
164. Kellermann, G., Luyten-Kellermann, M., and Shaw, C. R. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet., 25: 327–331, 1973.
165. Kensler, C. J. The influence of diet on the riboflavin content and the ability of rat liver slices to destroy the carcinogen N,N-dimethyl-ρ-aminoazobenzene. J. Biol. Chem., 179: 1079-1084, 1949.
166. Kensler, C. J., Sugiura, K., Young, N. F., Halter, C. R., and Rhoads, C. P. Partial protection of rats by riboflavin with casein against liver cancer caused by dimethylaminoazobenzene. Science (Wash. D. C.), 93: 308–310, 1941.
167. King, H. W. S., Osborne, M. R., Beland, F. A., Harvey, R. G., and Brookes, P. (±)-7α,8β-Dihydroxy-9β,10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene is an intermediate in the metabolism and binding to DNA of benzo-[a]pyrene. Proc. Natl. Acad. Sci. U. S. A., 73: 2679–2681, 1976.
168. King, H. W. S., Osborne, M. R., and Brookes, P. The metabolism and DNA binding of 3-methylcholanthrene. Int. J. Cancer, 20: 564–571, 1977.
169. King, H. W. S., Osborne, M. R., and Brookes, P. The identification of 3-methyicholanthrene-9, 10-dihydrodiol as an intermediate in the binding of 3-methylcholanthrene to DNA in cells in culture. Chem.-Biol. Interact., 20: 367–371, 1978.
170. Klingenberg, M. Pigments of rat liver microsomes. Arch. Biochem. Biophys., 75: 376–386, 1958.
171. Kolmodin, B., Azarnoff, D. L., and Sjoqvist, F. Effect of environmental factors on drug metabolism: decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides. Clin. Pharmacol. Ther., 10: 638–642, 1969.
172. Koreeda, M., Moore, P. D., Wislocki, P. G., Levin, W., Conney, A. H., Yagi, H., and Jerina, D. M. Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA and protein of mouse skin occurs with high stereoselectivity. Science (Wash. D. C.), 199: 778–781, 1978.
173. Krampl, V., and Kontsekova, M. Effect of polychlorinated biphenyls on the elimination rate of antipyrine from plasma of rats and man. Bull. Environ. Contam. Toxicol., 20: 191–198, 1978.
174. Kuntzman, R., Jacobson, M., Schneidman, K., and Conney, A. H. Similarities between oxidative drug-metabolizing enzymes and steroid hydroxylases in liver microsomes. J. Pharmacol. Exp. Ther., 146: 280–285, 1964.
175. Kuntzman, R., Levin, W., Jacobson, M., and Conney, A. H. Studies on microsomal hydroxylation and the demonstration of a new carbon monoxide binding pigment in liver microsomes. Life Sci., 7: 215–224, 1968.
176. Kuntzman, R., Mark, L. C., Brand, L., Jacobson, M., Levin, W., and Conney, A. H. Metabolism of drugs and carcinogens by human liver enzymes. J. Pharmacol. Exp. Ther., 152: 151–156, 1966.
177. Kuntzman, R., Sansur, M., and Conney, A. H. Effect of drugs and insecticides on the anesthetic action of steroids. Endocrinology, 77: 952–954, 1965.
178. Kunz, W., Schaude, G., and Thomas, C. The effect of phenobarbital and halogenated hydrocarbons on nitrosamine carcinogenesis. Z. Krebsforsch., 72: 291–304, 1969.
179. Kupfer, D. Endogenous substrates of monooxygenases: fatty acids and prostaglandins. In: J. B. Schenkman and D. Kupfer (eds.), Hepatic Cytochrome P-450 Monooxygenase System, pp. 157–187. New York: Pergamon Press, 1982.
180. Larsen, P. R., Atkinson, A. J., Jr., Wellman, H. N., and Goldsmith, R. E. The effect of diphenylhydantoin on thyroxine metabolism in man. J. Clin. Invest., 49: 1266–1279, 1970.
181. Lasker, J. M., Huang, M.-T., and Conney, A. H. In vivo activation of zoxazolamine metabolism by flavone. Science (Wash. D. C.). 216: 1419–1421, 1982.
182. LaVoie, E. J., Amin, S., Hecht, S. S., Furuya, K., and Hoffmann, D. Tumour initiating activity of dihydrodiols of benzo[b]fluoranthene, benzo[/]fluoranthene, and benzo[k]fluoranthene. Carcinogenesis (Lond.), 3:49-52,1982.
183. LaVoie, E. J., Tulley-Freiler, L., Bedenko, V., and Hoffmann, D. On the metabolic activation of methylated phenanthrenes. Proc. Am. Assoc. Cancer Res., 22: 94, 1981.
184. Levin, W. Purification of liver microsomal cytochrome P-450: Hopes and promises. In: V. Ullrich, I. Roots, A. Hlldebrandt, R. W. Estabrook, and A. H. Conney (eds.), Microsomes and Drug Oxidations, Proceedings of the Third International Symposium, pp. 735–747. New York: Pergamon Press, 1977.
185. Levin, W., Buening, M. K., Wood, A. W., Chang, R. L., Kedzierski, B., Thakker, D. R., Boyd, D. R., Gadaginamath, G. S., Armstrong, R. N., Yagi, H., Karie, J. M., Slaga, T. J., Jerina, D. M., and Conney, A. H. An enantiomeric interaction in the metabolism and tumorigenicity of (+)- and (-)-benzo[a]pyrene 7,8-oxide. J. Biol. Chem., 255: 9067–9074, 1980.
186. Levin, W., Buening, M. K., Wood, A. W., Chang, R. L., Thakker, D. R., Jerina, D. M., and Conney, A. H. Tumorigenic activity of 3-methylcholanthrene metabolites on mouse skin and in newborn mice. Cancer Res., 39: 3549–3553, 1979.
187. Levin, W., and Conney, A. H. Stimulatory effect of polycyclic hydrocarbons and aromatic azo derivatives on the metabolism of 7,12-dimethylbenz[a] anthracene. Cancer Res., 27: 1931–1938, 1967.
188. Levin, W., Conney, A. H., Alvares, A. P., Merkatz, I., and Kappas, A. Induction of benzo[a]pyrene hydroxylase in human skin. Science (Wash. D. C.), 176: 419-420, 1972.
189. Levin, W., Kuntzman, R., and Conney, A. H. Stimulatory effect of phenobarbital on the metabolism of the oral contraceptive 17a-ethynyl-estradiol-3-methyl ether (mestranol) by rat liver microsomes. Pharmacology, 19: 249–255, 1979.
190. Levin, W., Lu, A. Y. H., Ryan, D., Wood, A. W., Kapitulnik, J., West, S., Huang, M.-T., Conney, A. H., Thakker, D. R., Holder, G., Yagi, H., and Jerina, D. M. Properties of the liver microsomal monooxygenase system and epoxide hydrase: factors influencing the metabolism and mutagenicity of benzo[a]pyrene. In: H. H. Hiatt, J. D. Watson, and J. A. Winsten (eds.), Origins of Human Cancer, pp. 659–682. Cold Spring Harbor, N. Y.: Cold Spring Harbor Laboratory, 1977.
191. Levin, W., Thakker, D. R., Wood, A. W., Chang, R. L., Lehr, R. E., Jerina, D. M., and Conney, A. H. Evidence that benzo[a]anthracene 3,4-diol-1, 2-epoxide is an ultimate carcinogen on mouse skin. Cancer Res., 38:1705-1710, 1978.
192. Levin, W., Welch, R. M., and Conney, A. H. Effect of chronic phenobarbital treatment on the liver microsomal metabolism and uterotropic action of 17β-estradiol. Endocrinology, 80: 135-140, 1967.
193. Levin, W., Welch, R. M., and Conney, A. H. Decreased uterotropic potency of oral contraceptives in rats pretreated with phenobarbital. Endocrinology, 83: 149–156, 1968.
194. Levin, W., Welch, R. M., and Conney, A. H. Effect of phenobarbital and other drugs on the metabolism and uterotropic action of estradiol-17β and estrone. J. Pharmacol. Exp. Ther., 159: 362–371, 1968.
195. Levin, W., Welch, R. M., and Conney, A. H. Inhibitory effect of phenobarbital or chlordane pretreatment on the androgen-induced increase in seminal vesicle weight in the rat. Steroids, 13: 155–161, 1969.
196. Levin, W., Welch, R. M., and Conney, A. H. Increased liver microsomal androgen metabolism by phenobarbital: correlation with decreased androgen action on the seminal vesicles of the rat. J. Pharmacol. Exp. Ther., 188: 287–292, 1974.
197. Levin, W., Wood, A. W., Chang, R. L., Ittah, Y., Croisy-Delcey, M., Yagi, H., Jerina, D. M., and Conney, A. H. Exceptionally high tumor-initiating activity of benzo(c)phenanthrene bay-region diol-epoxides on mouse skin. Cancer Res., 40: 3910–3914, 1980.
198. Levin, W., Wood, A. W., Chang, R., Ryan, D., Thomas, P., Yagi, H., Thakker, D., Vyas, K., Boyd, C., Chu, S.-Y., Conney, A. H., and Jerina, D. M. Oxidative metabolism of polycyclic aromatic hydrocarbons to ultimate carcinogens. Drug Metab. Rev., 13: 555–580, 1982.
199. Levin, W., Wood, A. W., Chang, R. L., Slaga. T. J., Yagi, H., Jerina, D. M., and Conney, A. H. Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a]pyrene on mouse skin. Cancer Res., 37: 2721–2725, 1977.
200. Levin, W., Wood. A. W., Chang, R. L., Yagi, H., Mah, H. D., Jerina, D. M., and Conney, A. H. Evidence for bay region activation of chrysene-1,2-dihydrodiol to an ultimate carcinogen. Cancer Res., 38: 1831-1834,1978.
201. Levin, W., Wood, A. W., Wislocki, P. G., Kapitulnik, J., Yagi, H., Jerina, D. M., and Conney, A. H. Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin. Cancer Res., 37: 3356–3361, 1977.
202. Levin, W., Wood, A. W., Yagi, H., Dansette, P. M., Jerina, D. M., and Conney. A. H. Carcinogenicity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides on mouse skin. Proc. Natl. Acad. Sci. U. S. A., 73: 243–247, 1976.
203. Levin, W., Wood, A. W., Yagi, H., Jerina, D. M., and Conney, A. H. (±)-trans-7,8-Oihydroxy-7,8-dihydrobenzo(a)pyrene: a potent skin carcinogen when applied topically to mice. Proc. Natl. Acad. Sci. U. S. A., 73: 3867–3871, 1976.
204. Loeser, E. W., Jr. Studies on the metabolism of diphenylhydantoin (Dilantin). Neurology. 11: 424–429, 1961.
205. Loub, W. D., Wattenberg, L. W., and Davis, D. W. Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. J. Natl. Cancer Inst., 54: 985–988, 1975.
206. Lu, A. Y. H. and Coon, M. J. Role of hemoprotein P-450 in fatty acid ω-hydroxylation in a soluble enzyme system from liver microsomes. J. Biol. Chem., 243: 1331–1332, 1968.
207. Lu, A. Y. H., Junk, K. W., and Coon, M. J. Resolution of the cytochrome P-450-containing ω-hydroxylation system of liver microsomes into three components. J. Biol. Chem., 244: 3714–3721, 1969.
208. Lu, A. Y. H., Kuntzman, R., West, S., and Conney, A. H. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. I. Determination of substrate specificity by the cytochrome P-450 and P-448 fractions. Biochem. Biophys. Res. Commun., 42: 1200–1206, 1971.
209. Lu, A. Y. H., Kuntzman, R., West, S., Jacobson, M., and Conney, A. H. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. II. Role of the cytochrome P-450 and P-448 fractions in drug and steroid hydroxylations. J. Biol. Chem., 247: 1727–1734, 1972.
210. Lu, A. Y. H., and West, S. B. Multiplicity of mammalian microsomal cytochromes P-450. Pharmacol. Rev., 31: 277–295, 1980.
211. MacLeod, M. C., Cohen, G. M., and Selkirk, J. K. Metabolism and macromolecular binding of the carcinogen benzo(a)pyrene and its relatively inert isomer benzo(e)pyrene by hamster embryo cells. Cancer Res., 39: 3463–3470, 1979.
212. MacLeod, M. C. Levin, W., Conney, A. H., Lehr, R. E. Mansfield, B. K., Jerina, D. M., and Selkirk, J. K. Metabolism of benzo(e)pyrene by rat liver microsomal enzymes. Carcinogenesis (Lond.), 1: 165–173, 1980.
213. MacNicoll, A. D., Grover, P. L., and Sims, P. The metabolism of a series of polycyclic hydrocarbons by mouse skin maintained in short-term organ culture. Chem.-Biol. Interact., 29: 169–188, 1980.
214. Malaveille, C., Bartsch, H., Marquardt, H., Baker, S., Tierney, B., Hewer, A., Grover, P. L., and Sims. P. Metabolic activation of 3-methylcholanthrene: mutagenic and transforming activities of the 9,10-dihydrodiol. Biochem. Biophys. Res. Commun., 85:1568-1574, 1978.
215. Malaveille. C., Bartsch, H., Tierney, B., Grover, P. L., and Sims, P. Micro-some-mediated mutagenicities of the dihydrodiols of 7,12-dimethylbenz[a] anthracene: high mutagenic activity of the 3,4-dihydrodiol. Biochem. Biophys. Res. Commun., 83: 1468–1473, 1978.
216. Malaveille, C., Tierney, B., Grover, P. L., Sims, P., and Bartsch, H. High microsome-mediated mutagenicity of the 3,4-dihydrodiol of 7-methylbenz[a]anthracene in S. typhimurium TA 98. Biochem. Biophys. Res. Commun., 75: 427–433, 1977.
217. Marquardt, H., Baker, S., Tierney, B., Grover, P. L., and Sims, P. The metabolic activation of 7-methylbenz[a]anthracene: the induction of malignant transformation and mutation in mammalian cells by non-K-region dihydrodiols. Int. J. Cancer, 19: 828–833, 1977.
218. Marquardt, H., Baker, S., Tierney, B., Grover, P. L., and Sims, P. Induction of malignant transformation and mutagenesis by dihydrodiois derived from 7,12-dimethylbenz[a]anthracene. Biochem. Biophys. Res. Commun., 85: 357–362, 1978.
219. Mather, L. E., Tucker, G. T., Pflug, A. E., Lindop, M. J., and Wilkerson, C. Meperidine kinetics in man: intravenous injection in surgical patients and volunteers. Clin. Pharmacol. Ther., 17: 21–30, 1975.
220. Maurer, H. M., Wolff, J. A., Finster, M., Poppers, P. J., Pantuck, E., Kuntzman, R., and Conney, A. H. Reduction in concentration of total serum bilirubin in offspring of women treated with phenobarbitone during pregnancy. Lancet, 2: 122–124, 1968.
221. McLean, A. E. M., and Marshall, A. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone. Br. J. Exp. Pathol., 52: 322–329, 1971.
222. Meehan, T., and Straub, K. Double-stranded DNA stereoselectively binds benzo(a)pyrene diol epoxides. Nature (Lond.), 277: 410–412, 1979.
223. Melikian, A. A., LaVoie, E. J., Hecht, S. S., and Hoffmann, D. Influence of a bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide: DNA adducts in mouse skin. Cancer Res., 42: 1239-1242,1982.
224. Miller, E. C. Studies on the formation of protein-bound derivatives of 3,4-benzpyrene in the epidermal fraction of mouse skin. Cancer Res., 11: 100-108, 1951.
225. Miller, E. C., Miller, J. A., Brown, R. R., and MacDonald, J. C. On the protective action of certain polycyclic aromatic hydrocarbons against carcinogenesis by aminoazo dyes and 2-acetylaminofluorene. Cancer Res., 18: 469–477, 1958.
226. Miller, E. C., Miller, J. A., and Conney, A. H. On the mechanism of the methylcholanthrene inhibition of carcinogenesis by 3. -methyl-4-dimethylaminoazobenzene. Proc. Am. Assoc. Cancer Res., 1: 32, 1954.
227. Miller, E. C., Miller, J. A., Hirono, I., Sugimura, T., and Takayama, S. (eds.), Naturally Occurring Carcinogens-Mutagens and Modulators of Carcinogenesis. Baltimore: University Park Press, 1979.
228. Miller, E. C., Miller, J. A., Kline, B. E., and Rusch, H. P. Correlation of the level of hepatic riboflavin with the appearance of liver tumors in rats fed aminoazo dyes. J. Exp. Med., 88: 89–98, 1948.
229. Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., and Brodie, B. B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther., 187: 185–194, 1973.
230. Moore, P. D., Koreeda, M., Wislocki. P. G., Levin, W., Conney, A. H., Yagi, H., and Jerina, D. M. In vitro reactions of the diastereomeric 9,10-epoxides of (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene with poly-guanylic acid and evidence for formation of an enantiomer of each diastereomeric 9,10-epoxide from benzo[a]pyrene in mouse skin. In: D. M. Jerina (ed.), Drug Metabolism and Concepts, ACS Symposium Series No. 44, pp. 127–154. Washington, D. C.: American Chemical Society, 1977.
231. Moschei, R. C., Baird, W. M., and Dipple, A. Metabolic activation of the carcinogen 7,12-dimethylbenz[a]anthracene for DNA binding. Biochem. Biophys. Res. Commun., 76: 1092–1098, 1977.
232. Mueller, G. C., and Miller, J. A. The reductive cleavage of 4-dimethylaminoazobenzene by rat liver: reactivation of carbon dioxide-treated homogenates by riboflavin-adenine dinucleotide. J. Biol. Chem., 185: 145–154, 1950.
233. Nakanishi, K., Kasai. H., Cho, H., Harvey, R. G., Jeffrey, A. M., Jennette. K. W., and Weinstein, I. B. Absolute configuration of a ribonucleic acid adduct formed in vivo by metabolism of benzo[a]pyrene. J. Am. Chem. Soc., 99: 258-260, 1977.
234. Negishi, M., Swan, D. C., Enquist, L. W., and Nebert, D. W. Isolation and characterization of a cloned DNA sequence associated with the murine ah locus and a 3-methylcholanthrene-induced form of cytochrome P-450. Proc. Natl. Acad. Sci. U. S. A., 78: 800–804, 1981.
235. Newbold, R. F., and Brookes, P. Exceptional mutagenicity of a benzo[a] pyrene diol epoxide in cultured mammalian cells. Nature (Lond.), 261: 52–54, 1976.
236. Nordqvist, M., Thakker, D. R., Levin, W., Yagi, H., Ryan, D. E., Thomas, P. E., Conney, A. H., and Jerina, D. M. The highly tumorigenic 3,4-dihydrodiol is a principal metabolite formed from dibenzo(a,h)anthracene by liver enzymes. Mol. Pharmacol., 16: 643–655, 1979.
237. Nordqvist, M., Thakker, D. R., Vyas, K. P., Yagi, H., Levin, W., Ryan, D. E., Thomas, P. E., Conney, A. H., and Jerina, D. M. Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes. Mol. Pharmacol., 19: 168–178, 1981.
238. Norman, T. R., Burrows, G. D., Maguire, K. P., Rubinstein, G., Scoggins, B. A., and Davies, B. Cigarette smoking and plasma nortriptyline levels. Clin. Pharmacol. Ther., 21: 453–456, 1977.
239. Ohnhaus, E. E., Burgi, H., Burger, A., and Studer, H. The effect of antipyrine, phenobarbital and rifampicin on thyroid hormone metabolism in man. Eur. J. Clin. Invest. 11: 381–387, 1981.
240. Ohnishi, K., and Lieber, C. S. Reconstitution of the microsomal ethanol-oxidizing system. Qualitative and quantitative changes of cytochrome P-450 after chronic ethanol consumption. J. Biol. Chem., 252: 7124–7131, 1977.
241. Omura, T., and Sato, R. A new cytochrome in liver microsomes. J. Biol. Chem., 237: 1375–1376, 1962.
242. Orrenius, S., and Ernster, L. Phenobarbital-induced synthesis of the oxidative demethylating enzymes of rat liver microsomes. Biochem. Biophys. Res. Commun. 16: 60–65, 1964.
243. Pamukcu, A. M., Wattenberg, L. W., Price, J. M., and Bryan, G. T. Phenothiazine inhibition of intestinal and urinary bladder tumors induced in rats by bracken fern. J. Natl. Cancer Inst., 47:155-159, 1971.
244. Pantuck, E. J., Hsiao, K.-C., Conney, A. H., Garland. W., Kappas, A., and Anderson, K. Effect of charcoal-broiled beef on phenacetin metabolism in man. Science (Wash. D. C.), 194: 1055–1057, 1976.
245. Pantuck, E. J., Hsiao, K.-C., Kuntzman, R., and Conney, A. H. Intestinal metabolism of phenacetin in the rat: effect of charcoal-broiled beef and rat chow. Science (Wash. D. C.), 187: 744–746, 1975.
246. Pantuck, E. J., Hsiao. K.-C., Loub, W. D., Wattenberg, L. W., Kuntzman, R., and Conney, A. H. Stimulatory effect of vegetables on intestinal drug metabolism in the rat. J. Pharmacol. Exp. Ther., 198, 278–283, 1976.
247. Pantuck, E. J., Hsiao, K.-C., Maggio, A., Nakamura, K., Kuntzman, R., and Conney, A. H. Effect of cigarette smoking on phenacetin metabolism. Clin. Pharmacol. Ther., 15: 9–17, 1974.
248. Pantuck, E. J., Kuntzman, R., and Conney, A. H. Decreased concentration of phenacetin in plasma of cigarette smokers. Science (Wash. D. C.), 175: 1248–1250, 1972.
249. Pantuck, E. J., Pantuck, C. B., Garland, W. A., Min, B., Wattenberg, L. W., Anderson, K. E., Kappas, A., and Conney, A. H. Stimulatory effect of brusseis sprouts and cabbage on human drug metabolism. Clin. Pharmacol. Ther., 25: 88–95, 1979.
250. Park, B. K. Assessment of urinary 6β-hydroxycortisol as an in vivo index of mixed-function oxygenase activity. Br. J. Clin. Pharmacol., 12: 97–102, 1981.
251. Parsons, W. D., and Nelms, A. H. Effect of smoking on caffeine clearance. Clin. Pharmacol. Ther., 24: 40–45, 1978.
252. Peraino, C., Fry, R. J. M., and Grube, D. D. Drug-induced enhancement of hepatic tumorigenesis. Carcinog. Compr. Surv., 2: 421–432, 1978.
253. Peraino, C., Staffeldt, E. F., Haugen, D. A., Lombard, L. S., Stevens, F. J., and Fry, R. J. M. Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetytaminofluorene-induced hepatic tumorigenesis. Cancer Res., 40: 3268–3273, 1980.
254. Poland, A., Glover, E., and Kende, A. S. Stereospecific, high affinity binding of 2,3.7,8-tetrachlorodibenzo-ρ-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem., 251: 4936–4946, 1976.
255. Poland, A., Smith, D., Kuntzman, R., Jacobson, M., and Conney, A. H. Effect of intensive occupational exposure to DDT on phenylbutazone and cortisol metabolism in human subjects. Clin. Pharmacol. Ther., 11: 724–732. 1970.
256. Remmer, H. Die Beschleunigung der Evipanoxydation und der Demethylierung von Methylaminoantipyrin durch Barbiturate. Arch. Exp. Pathol. Pharmakol., 237: 296–307, 1959.
257. Remmer, H., and Alsleben, B. Die Aktivierung der Entgiftung in den Lebermikrosomen wahrend der Gewohnung. Klin. Wochenschr., 36: 332–333, 1958.
258. Remmer, H., and Merker, H. J. Effect of drugs on the formation of smooth endoplasmic reticulum and drug-metabolizing enzymes. Ann. N. Y. Acad. Sci., 123: 79–97, 1965.
259. Remsen, J., Jerina, D., Yagi, H., and Cerutti, P. In vitro reaction of radioactive 7β,8α-dihydroxy-9α, 10α-epoxy-7,8,9,10-tetrahydrobenzo(a)-pyrene and 7β,8α-dihydroxy-9β,10β-epoxy-7,8,9,10-tetrahydrobenzo(a)-pyrene with DNA. Biochem. Biophys. Res. Commun., 74:934-940, 1977.
260. Richardson, H. L., Stler, A. R., and Borsos-Nachtnebel, E. Liver tumor inhibition and adrenal histologic responses in rats to which 3. -methyl-4-dimethylaminoazobenzene and 20-methytcholanthrene were simultaneously administered. Cancer Res., 12: 356–361, 1952.
261. Roots, I., Holbe, R., Hovermann, W., Nigam, S., Heinemeyer, G., and Hildebrandt, A. G. Quantitative determination by HPLC of urinary 6β-hydroxycortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs. Eur. J. Clin. Pharmacol., 16: 63–71, 1979.
262. Rose, J. Q., Barron, S. A., and Jusko, W. J. Phenytoin disposition in smokers and nonsmokers. Int. J. Clin. Pharmacol., 16: 547–550, 1978.
263. Ryan, D., Lu, A. Y. H., Kawalek, J., West, S. B., and Levin, W. Highly purified cytochrome P-448 and P-450 from rat liver microsomes. Biochem. Biophys. Res. Commun., 64: 1134–1141, 1975.
264. Ryan, D. E., Thomas, P. E., Korzeniowski, D., and Levin, W. Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital and 3-methylcholanthrene. J. Biol. Chem., 254:1365-1374, 1979.
265. Ryan, D. E., Thomas, P. E., and Levin, W. Hepatic microsomal cytochrome P-450 from rats treated with isosafrole. Purification and characterization of four enzymic forms. J. Biol. Chem., 255: 7941–7955, 1980.
266. Ryan, D. E., Thomas, P. E., and Levin, W. Purification and characterization of a minor form of hepatic microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls. Arch. Biochem. Biophys., 216: 272–288, 1982.
267. Ryan, K., and Engel, L. Hydroxylation of steroids at carbon 21. J. Biol. Chem., 225: 103–114, 1957.
268. Sayer, J. M., Yagi, H., Wood, A. W., Conney, A. H., and Jerina, D. M. An extremely facile reaction between the ultimate carcinogen benzo(a)pyrene-7.8-diol-9,10-epoxide and ellagic acid. J. Am. Chem. Soc., 104: 5562–5564, 1982.
269. Schlede, E., Kuntzman, R., and Conney, A. H. Stimulatory effect of benzo-[a]pyrene and phenobarbital pretreatment on the biliary excretion of benzo[a]pyrene metabolites in the rat. Cancer Res., 30: 2898-2904, 1970.
270. Schlede, E., Kuntzman, R., Haber, S., and Conney, A. H. Effect of enzyme induction on the metabolism and tissue distribution of benzo[a]pyrene. Cancer Res., 30: 2893–2897, 1970.
271. Selkirk, J. K., Croy, R. G., Roller, P. P., and Gelboin, H. V. High-pressure liquid chromatographic analysis of benzo(a)pyrene metabolism and covalent binding and the mechanism of action of 7,8-benzoflavone and 1,2-epoxy-3,3,3-trichloropropane. Cancer Res., 34: 3474–3480, 1974.
272. Shinohara, K., and Cerutti, P. A. Formation of benzo(a)pyrene-DNA adducts in peripheral human lung tissue. Cancer Lett., 3: 303–309, 1977.
273. Shinohara, K., and Cerutti, P. A. Excision repair of benzo(a)pyrene-deoxyguanosine adducts in baby hamster kidney 21/C13 cells and in secondary mouse embryo fibroblasts C57BL/6J. Proc. Natl. Acad. Sci. U. S. A., 74: 979–983, 1977.
274. Sims, P. The carcinogenic activities in mice of compounds related to 3-methylcholanthrene. Int. J. Cancer, 2: 505–508, 1967.
275. Sims, P. Qualitative and quantitative studies on the metabolism of a series of aromatic hydrocarbons by rat-liver preparations. Biochem. Pharmacol., 19: 795–818, 1970.
276. Sims, P., Grover, P. L., Swaisland, A., Pal, K., and Hewer, A. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature (Lond.), 252: 326–328, 1974.
277. Sladek, N. E., and Mannering, G. J. Evidence for a new P-450 hemoprotein In hepatic microsomes from methylcholanthrene treated rats. Biochem. Biophys. Res. Commun., 24: 668–674, 1966.
278. Slaga, T. J., Bracken, W. M., Dresner, S., Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H. Skin tumor-initiating activities of the twelve isomeric phenols of benzo(a)pyrene. Cancer Res., 38: 678–681, 1978.
279. Slaga, T. J., Bracken, W. J., Gleason, G., Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H. Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides. Cancer Res., 39: 67–71, 1979.
280. Slaga, T. J., Bracken, W. M., Viaje, A., Berry, D. L., Fischer, S. M., Miller, D. R., Levin, W., Conney, A. H., Yagi, H., and Jerina, D. M. Tumor initiating and promoting activities of various benzo(a)pyrene metabolites in mouse skin. Carcinog. Compr. Surv., 3: 371–382, 1978.
281. Slaga, T. J., Bracken, W. M., Viaje, A., Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H. Comparison of the tumor-initiating activities of benzo(a)pyrene arene oxides and diol epoxides. Cancer Res., 37: 4130–4133, 1977.
282. Slaga, T. J., Gleason, G. L., DiGiovanni, J., Sukumaran, K. B., and Harvey, R. G. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. Cancer Res., 39: 1934–1936, 1979.
283. Slaga. T. J., Gleason. G. L., Mills, G., Ewald, L., Fu, P. P., Lee, H. M., and Harvey, R. G. Comparison of the skin tumor-intiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons. Cancer Res., 40:1981-1984, 1980.
284. Slaga, T. J., Huberman, E., Selkirk, J. K., Harvey, R. G., and Bracken, W. M. Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides. Cancer Res., 38: 1699–1704, 1978.
285. Slaga, T. J., Viaje, A., Berry, D. L., Bracken, W., Buty, S. G., and Scribner, J. D. Skin tumor initiating ability of benzo[a]pyrene 4,5-, 7,8-, and 7,8-diol-9,10-epoxides and 7,8-diol. Cancer Lett., 2: 115–122, 1976.
286. Southren, A. L., Gordon, G. G., Tochimoto, S., Krikun, E., Krieger, D., Jacobson, M., and Kuntzman, R. Effect of N-phenylbarbital (phetharbital) on the metabolism of testosterone and cortisol in man. J. Clin. Endocrinol. Metab., 29: 251–256, 1969.
287. Stamp, T. C. B., Round, J. M., Rowe, D. J. F., and Haddad, J. G. Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs. Br. Med. J., 4: 9–12, 1972.
288. Tawfic, H. N. Studies on ear duct tumors in rats. Part II: Inhibitory effect of methylcholanthrene and 1,2-benzanthracene on tumor formation by 4-dimethylaminostilbene. Acta Pathol. Jpn., 15: 255–260, 1965.
289. Thakker, D. R., Levin, W., Buening, M., Yagi, H., Lehr, R. E., Wood, A. W., Conney, A. H., and Jerina, D. M. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo(e)pyrene 9,10-dihydrodiol to bay-region diol epoxides. Cancer Res., 41: 1389–1396, 1981.
290. Thakker, D. R., Levin, W., Stoming, T. A., Conney, A. H., and Jerina, D. M. Metabolism of 3-methyicholanthrene by rat liver microsomes and a highly purified monooxygenase system with and without epoxide hydrase. Carcinog. Compr. Surv., 3: 253–264, 1978.
291. Thakker, D. R., Levin, W., Wood, A. W., Conney, A. H., Stoming, T. A., and Jerina, D. M. Metabolic formation of 1,9,10-trihydroxy-9,10-dihydro-3-methylcholanthrene: a potential proximate carcinogen from 3-methylcholanthrene. J. Am. Chem. Soc., 100: 645–647, 1978.
292. Thakker, D. R., Levin, W., Yagi, H., Conney, A. H., and Jerina, D. M. Regio-and stereoselectivity of hepatic cytochrome P-450 toward polycyclic aromatic hydrocarbon substrates. In: R. Snyder, D. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, and C. Witmer (eds.), Biological Reactive Intermediates—II, Part A, pp. 525–539. New York: Plenum Publishing Corporation, 1982.
293. Thakker, D. R., Levin, W., Yagi, H., Ryan, D., Thomas, P. E., Karle, J. M., Lehr, R. E., Jerina, D. M., and Conney, A. H. Metabolism of benzo(a)anthracene to its tumorigenic 3,4-dihydrodiol. Mol. Pharmacol., 15: 138–153, 1979.
294. Thakker, D. R., Levin, W., Yagi, H., Turujman, S., Kapadia, D., Conney, A. H., and Jerina, D. M. Absolute stereochemistry of the fransdihydrodiols formed from benzo(a)anthracene by liver microsomes. Chem.-Biol. Interact., 27: 145–161, 1979.
295. Thakker, D. R., Yagi, H., Akagi, H., Koreeda, M., Lu, A. Y. H., Levin, W., Wood, A. W., Conney, A. H., and Jerina, D. M. Metabolism of benzo(a] pyrene: VI. Stereoselective metabolism of benzo[a]pyrene and benzo[a] pyrene 7,8-dihydrodiol to diol epoxides. Chem.-Biol. Interact., 16: 281–300, 1977.
296. Thakker, D. R., Yagi, H., Lehr, R. E., Levin, W., Buening, M., Lu, A. Y. H., Chang, R. L., Wood, A. W., Conney, A. H., and Jerina, D. M. Metabolism of trans-9,10-dihydroxy-9,10-dihydrobenzo(a]pyrene occurs primarily by arylhydroxylation rather than formation of a diol epoxide. Mol. Pharmacol., 14: 502–513, 1978.
297. Thakker, D. R., Yagi, H., Levin, W., Lu, A. Y. H., Conney, A. H., and Jerina, D. M. Stereospecificity of microsomal and purified epoxide hydrase from rat liver: hydration of arene oxides of polycyclic hydrocarbons. J. Biol. Chem., 252: 6328–6334, 1977.
298. Thakker, D. R., Yagi, H., Lu, A. Y. H., Levin, W., Conney, A. H., and Jerina, D. M. Metabolism of benzo(a)pyrene. Conversion of (±-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene to the highly mutagenic 7,8-diol-9,10-epoxides. Proc. Natl. Acad. Sci. U. S. A., 73: 3381–3385, 1976.
299. Thomas, P. E., Korzeniowski, D., Ryan, D., and Levin, W. Preparation of monospecific antibodies against two forms of rat liver cytochrome P-450 and quantitation of these antigens in microsomes. Arch. Biochem. Biophys., 192: 524–532, 1979.
300. Thomas, P. E., Reik, L. M., Ryan, D. E., and Levin, W. Regulation of three forms of cytochrome P-450 and epoxide hydrolase in rat liver microsomes. Effects of age, sex, and induction. J. Biol. Chem., 256: 1044-1052,1981.
301. Thompson, R. P. H., Eddleston, A.L.W.F., and Williams, R. Low plasma-bilirubin in epileptics on phenobarbitone. Lancet, 1: 21–22, 1969.
302. Tierney, B., Hewer, A., MacNicoll, A. D., Gervasi, P. G., Rattle, H., Walsh, C., Grover, P. L., and Sims, P. The formation of dihydrodiols by the chemical or enzymic oxidation of benz[a]anthracene and 7,12-dimethyt-benzfajanthracene. Chem.-Biol. Interact., 23: 243–257, 1978.
303. Tierney, B., Hewer, A., Walsh, C., Grover, P. L., and Sims, P. The metabolic activation of 7-methylbenz(a]anthracene in mouse skin. Chem.-Biol. Interact., 18: 179–193, 1977.
304. Toth, B. A critical review of experiments in chemical carcinogenesis using newborn animals. Cancer Res., 28: 727–738, 1968.
305. Toth, B., and Shubik, P. Carcinogenesis in AKR mice injected at birth with benzo(a)pyrene and dimethylnitrosamine. Cancer Res., 27: 43–51, 1967.
306. Toxicants Occurring Naturally in Foods. Committee on Food Protection, Food and Nutrition Board, National Research Council. Washington, D. C.: National Academy of Sciences, 1973.
307. Vesell, E. Gene-environment interactions in drug metabolism. In: P. Turner (ed.), Clinical Pharmacology and Therapeutics, pp. 63–79. London: Macmillan Publishers, Ltd., 1980.
308. Vesell, E. S., and Page, J. G. Genetic control of drug levels in man: phenylbutazone. Science (Wash. D. C.), 159: 1479–1480, 1968.
309. Vesell, E. S., and Page, J. G. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man. J. Clin. Invest., 48: 2202-2209, 1969.
310. Vigny, P., Duquesne, M., Coulomb, H., Lacombe, C., Tierney, B., Grover, P. L., and Sims, P. Metabolic activation of polycyclic hydrocarbons. Fluorescence spectral evidence is consistent with metabolism at the 1,2- and 3,4-double bonds of 7-methylbenz[a]anthracene. FEBS Lett., 75: 9–12, 1977.
311. Vigny, P., Duquesne, M., Coulomb, H., Tierney, B., Grover, P. L., and Sims, P. Fluorescence spectral studies on the metabolic activation of 3-methylcholanthrene and 7,12-dimethylbenz[a]anthracene in mouse skin. FEBS Lett., 82: 278–282, 1977.
312. Vigny, P., Ginot, Y. M., Kindts, M., Cooper, C. S., Grover, P. L., and Sims, P. Fluorescence spectral evidence that benzo[a]pyrene is activated by metabolism in mouse skin to a diol-epoxide and a phenol-epoxide. Carcinogenesis (Lond.), 7: 945–950, 1980.
313. Villeneuve, J.P., Mavier, P., and Joly, J.G. Ethanol-induced cytochrome P-450: catalytic activity after partial purification. Biochem. Biophys. Res. Commun., 70: 723–728, 1976.
314. Walz, F. G., Jr., Vlasuk, G. P., Omiecinski, C. J., Bresnick, E., Thomas, P. E., Ryan, D. E., and Levin, W. Multiple, immunoidentical forms of phenobarbital-induced rat liver cytochromes P-450 are encoded by different mRNAs. J. Biol. Chem., 257: 4023–4026, 1982.
315. Wattenberg, L. W. Studies of polycyclic hydrocarbon hydroxylases of the intestine possibly related to cancer. Effect of diet on benzpyrene hydroxylase activity. Cancer (Phila.), 28: 99–102, 1971.
316. Wattenberg, L. W. Inhibitors of chemical carcinogenesis. Adv. Cancer Res., 26: 197–226, 1978.
317. Wattenberg, L. W., and Leong, J. L. Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. Cancer Res., 30: 1922–1925, 1970.
318. Weiner, M., Shapiro, S., Axelrod, J., Cooper, J. R., and Brodie, B. B. The physiological disposition of dlcumarol in man. J. Pharmacol. Exp. Ther., 99: 409-420, 1950.
319. Weinstein, I. B., Jeffrey, A. M., Jennette, K. W., Blobstein, S. H., Harvey, R. G., Harris, C., Autrup, H., Kasai, H., and Nakanishi, K. Benzo[a]pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. Science (Wash. D. C.). 193: 592–595, 1976.
320. Weisburger, J. H., Weisburger, E. K., and Morris, H. P. Orientation of biochemical hydroxylation in aromatic compounds. Science (Wash. D. C.), 125: 503, 1957.
321. Welch, R. M., Gommi, B., Alvares, A. P., and Conney, A. H. Effect of enzyme induction on the metabolism of benzo[a]pyrene and 3-methyl-4-monomethylaminoazobenzene in the pregnant and fetal rat. Cancer Res., 32: 973–978, 1972.
322. Welch, R. M., Harrison, Y. E., Conney, A. H., and Burns, J. J. An experimental model in dogs for studying interactions of drugs with bishydroxycoumarin. Clin. Pharmacol. Ther., 10: 817–825, 1969.
323. Welch, R. M., Harrison, Y. E., Conney, A. H., Poppers, P. J., and Finster, M. Cigarette smoking: stimulatory effect on the metabolism of 3.4-benzpyrene by enzymes in human placenta. Science (Wash. D. C.), 160: 541–542, 1968.
324. Welch, R. M., Harrison, Y. E., Gommi, B. W., Poppers, P. J., Finster, M., and Conney, A. H. Stimulatory effect of cigarette smoking on the hydroxylation of 3,4-benzpyrene and the N-demethylation of 3-methyl-4-mono-methylaminoazobenzene by enzymes in human placenta. Clin. Pharmacol. Ther., 10: 100–109, 1969.
325. Welch, R. M., Levin, W., Kuntzman, R., Jacobson, M., and Conney, A. H. Effect of halogenated hydrocarbon insecticides on the metabolism and uterotropic action of estrogens in rats and mice. Toxicol. Appl. Pharmacol., 19: 234–246, 1971.
326. Welch, R. M., Loh, A., and Conney, A. H. Cigarette smoke: stimulatory effect on metabolism of 3,4-benzpyrene by enzymes in rat lung. Life Sci., 10: 215–221, 1971.
327. Whalen, D. L., Montemarano, J. A., Thakker, D. R., Yagi, H., and Jerina, D. M. Changes of mechanisms and product distributions in the hydrolysis of benzo(a]pyrene-7,8-diol 9,10-epoxide metabolites induced by changes in pH. J. Am. Chem. Soc., 99: 5522–5524, 1977.
328. Wiebel, F. J., and Gelboin, H. V. Aryl hydrocarbon (benzo[a]pyrene) hydroxylases in liver from rats of different age, sex and nutritional status. Distinction of two types by 7,8-benzoflavone. Biochem. Pharmacol., 24: 1511–1515, 1975.
329. Wiebel, F. J., Leutz, J. C., Diamond, L., and Gelboin, H. V. Aryl hydrocarbon (benzo[a]pyrene) hydroxylase in microsomes from rat tissues: differential inhibition and stimulation by benzofiavones and organic solvents. Arch. Biochem. Biophys., 144: 78–86, 1971.
330. Wislocki, P. G., Buening, M. K., Levin, W., Lehr, R. E., Thakker, D. R., Jerina, D. M., and Conney, A. H. Tumorigenicity of the diastereomeric benz(a)anthracene 3,4-diol-1,2-epoxides and the (+)- and (-)-enantiomers of benz(a)anthracene 3,4-dihydrodiol in newborn mice. J. Natl. Cancer Inst., 63: 201–204, 1979.
331. Wislocki, P. G., Chang, R. L., Wood, A. W., Levin, W., Yagi, H., Hernandez, O., Mah, H. D., Dansette, P. M., Jerina, D. M., and Conney, A. H. High carcinogenicity of 2-hydroxybenzo[a)pyrene on mouse skin. Cancer Res., 37: 2608–2611, 1977.
332. Wislocki, P. G., Fiorentini, K. M., Fu, P. P., Chou, M. W., Yang, S. K., and Lu, A. Y. H. Tumor-initiating activity of the dihydrodiols of 8-methylbenz-[a]anthracene and 8-hydroxymethylbenz[a]anthracene. Carcinogenesis (Lond.), 2: 507–509, 1981.
333. Wislocki, P. G., Gadek, K. M., Chou, M. W., Yang, S. K., and Lu, A. Y. H. Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives. Cancer Res., 40: 3661–3664, 1980.
334. Wislocki, P. G., Juliana, M. M., MacDonald, J. S., Chou, M. W., Yang, S. K., and Lu, A. Y. H. Tumorigenicity of 7,12-dimethylbenz[a]anthracene, its hydroxymethylated derivatives and selected dihydrodiols in the newborn mouse. Carcinogenesis (Lond.), 2: 511-514, 1981.
335. Wislocki, P. G., Kapitulnik, J., Levin, W., Lehr, R., Schaefer-Ridder, M., Karle, J. M., Jerina, D. M., and Conney, A. H. Exceptional carcinogenic activity of benz(a]anthracene 3,4-dihydrodiol in the newborn mouse and the bay region theory. Cancer Res., 38: 693–696, 1978.
336. Wislocki, P. G., Kapitulnik, J., Levin, W., Yagi, H., Jerina, D. M., and Conney, A. H. Tumorigenicity of benzo[a]pyrene 4,5-, 7,8-, 9,10- and 11,12-oxides in newborn mice. Cancer Lett., 5:191-197, 1978.
337. Wislocki, P. G., Miller, E. C., Miller, J. A., McCoy, E. C., and Rosenkranz, H. S. Carcinogenic and mutagenic activities of safrole, 1‘-hydroxysafrole, and some known or possible metabolites. Cancer Res., 37: 1883–1891, 1977.
338. Wislocki, P. G., Wood, A. W., Chang, R. L., Levin, W., Yagi, H., Hernandez, O., Dansette, P. M., Jerina, D. M., and Conney, A. H. Mutagenicity and cytotoxicity of benzo[a]pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells. Cancer Res., 36: 3350-3357, 1976.
339. Wislocki, P. G., Wood, A. W., Chang, R. L., Levin, W., Yagi, H., Hernandez, O., Jerina, D. M., and Conney, A. H. High mutagenicity and toxicity of a diol epoxide derived from benzo[a)pyrene. Biochem. Biophys. Res. Commun., 68: 1006–1012, 1976.
340. Wong, T. K., Chiu, P.L., Fu, P. P., and Yang, S. K. Metabolic study of 7-methylbenzo[a]pyrene with rat liver microsomes: separation by reversed-phase and normal-phase high performance liquid chromatography and characterization of metabolites. Chem.-Biol. Interact., 36: 153-166, 1981.
341. Wood, A. W., Chang, R. L., Huang, M. T., Levin, W., Lehr, R. E., Kumar, S., Thakker, D. R., Yagi, H., Jerina, D. M., and Conney, A. H. Mutagenicity of benzo(e)pyrene and triphenylene tetrahydroepoxides and diol-epoxides in bacterial and mammalian cells. Cancer Res., 40: 1985-1989, 1980.
342. Wood, A. W., Chang, R. L., Levin, W., Lehr, R., Kumar, S., Schaefer-Ridder, M., Jerina, D. M., and Conney, A. H. Mutagenic activity of diol epoxides of benz[a]acridine (B[a]ACR) and benz[c]acridine (B(c]ACR) in bacterial and mammalian cells. In: Proceedings of the 13th International Cancer Congress, Seattle, Wash., September 8 to 15, 1982, Abstract 918, p. 164.
343. Wood, A. W., Chang, R. L., Levin, W., Lehr, R. E., Schaefer-Ridder, M., Karle, J. M., Jerina, D. M., and Conney, A. H. Mutagenicity and cytotoxicity of benzfajanthracene diol epoxides and tetrahydroepoxides: exceptional activity of the bay region 1,2-epoxides. Proc. Natl. Acad. Sci. U. S. A., 74: 2746–2750, 1977.
344. Wood, A. W., Chang, R. L., Levin, W., Ryan, D. E., Thomas, P. E., Croisy-Delcey, M., Ittah, Y., Yagi, H., Jerina, D. M., and Conney, A. H. Mutagenicity of the dihydrodiols and bay-region diol-epoxides of benzo(c)phenanthrene in bacterial and mammalian cells. Cancer Res., 40: 2876–2883, 1980.
345. Wood, A. W., Chang, R. L., Levin, W., Ryan, D. E., Thomas, P. E., Lehr, R. E., Kumar, S., Sardella, D. J., Boger, E., Yagi, H., Sayer, J. M., Jerina, D. M., and Conney, A. H. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene. Cancer Res., 41: 2589–2597, 1981.
346. Wood, A. W., Chang, R. L., Levin, W., Ryan, D. E., Thomas, P. E., Mah, H. D., Karle, J. M., Yagi, H., Jerina, D. M., and Conney, A. H. Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides. Cancer Res., 39: 4069–4077, 1979.
347. Wood, A. W., Chang, R. L., Levin, W., Thomas, P. E., Ryan, E., Stoming, T. A., Thakker, D. R., Jerina, D. M., and Conney, A. H. Metabolic activation of 3-methylcholanthrene and its metabolites to mutagens towards bacteria and mammalian cells. Cancer Res., 38: 3398–3404, 1978.
348. Wood, A. W., Chang, R. L., Levin, W., Yagi, H., Thakker, D. R., Jerina, D. M., and Conney, A. H. Differences in mutagenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides. Biochem. Biophys. Res. Commun., 77: 1389–1396, 1977.
349. Wood, A. W., Goode, R. L., Chang, R. L., Levin, W., Conney, A. H., Yagi, H., Dansette, P. M., and Jerina, D. M. Mutagenic and cytotoxic activity of benzo(a]pyrene 4,5-, 7, 8-, and 9,10-oxides and the six corresponding phenols. Proc. Natl. Acad. Sci. U. S. A., 72: 3176–3180, 1975.
350. Wood, A. W., Huang, M.T., Chang, R. L., Newmark, H. L., Lehr, R. E., Yagi, H., Sayer, J. M., Jerina, D. M., and Conney, A. H. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. Proc. Natl. Acad. Sci. U. S. A., 79: 5513–5517, 1982.
351. Wood, A. W., Levin, W., Chang, R. L., Lehr, R. E., Schaefer-Ridder, M., Karle, J. M., Jerina, D. M., and Conney, A. H. Tumorigenicity of five dihydrodiols of benz[a]anthracene on mouse skin. Exceptional activity of benz[a]anthracene 3,4-dihydrodiol. Proc. Natl. Acad. Sci. U. S. A., 74: 3176–3179, 1977.
352. Wood, A. W., Levin, W., Chang, R. L., Yagi, H., Thakker, D. R., Lehr, R. E., Jerina, D. M., and Conney, A. H. Bay-region activation of carcinogenic polycyclic hydrocarbons. In: P. W. Jones and P. Leber (eds.), Polynuclear Aromatic Hydrocarbons, pp. 531–551. Ann Arbor, Mich.: Ann Arbor Science Publishers, Inc., 1979.
353. Wood, A. W., Levin, W., Lu, A. Y. H., Ryan, D., West, S. B., Lehr, R. E., Schaefer-Ridder, M., Jerina, D. M., and Conney, A. H. Mutagenicity of metabolically activated benzo(a)anthracene 3,4-dihydrodiol: evidence for bay region activation of carcinogenic polycyclic hydrocarbons. Biochem. Blophys. Res. Commun., 72: 680–686, 1976.
354. Wood, A. W., Levin, W., Lu, A. Y. H., Yagi, H., Hernandez, O., Jerina, D. M., and Conney, A. H. Metabolism of benzo(a)pyrene and benzo(a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. J. Biol. Chem., 251: 4882–4890, 1976.
355. Wood, A. W., Levin, W., Ryan, D., Thomas, P. E., Yagi, H., Mah, H. D., Thakker, D. R., Jerina, D. M., and Conney, A. H. High mutagenicity of metabolically activated chrysene 1,2-dihydrodiol: evidence for bay region activation of chrysene. Biochem. Biophys. Res. Commun., 78: 847–854, 1977.
356. Wood, A. W., Levin, W., Thakker, D. R., Yagi, H., Chang, R. L., Ryan, D. E., Thomas, P. E., Dansette, P. M., Whittaker, N., Turujman, S., Lehr, R. E., Kumar, S., Jerina, D. M., and Conney, A. H. Biological activity of benzo(e)pyrene: an assessment based on mutagenic activities and metabolic profiles of the polycyclic hydrocarbon and its derivatives. J. Biol. Chem., 254. 4408–4415, 1979.
357. Wood, A. W., Levin, W., Thomas, P. E., Ryan, D., Karle, J. M., Yagi, H., Jerina, D. M., and Conney, A. H. Metabolic activation of dibenzo-(a,h)anthracene and its dihydrodiols to bacterial mutagens. Cancer Res., 38: 1967–1973, 1978.
358. Wood, A. W., Sayer, J. M., Newmark, H. L., Yagi, H., Michaud, D. P., Jerina, D. M., and Conney, A. H. Mechanism of the inhibition of mutagenicity of a benzo[a]pyrene 7,8-diol-9,10-epoxide by riboflavin 5'-phosphate. Proc. Natl. Acad. Sci. U. S. A., 79: 5122–5126, 1982.
359. Wood, A. W., Wlslocki, P. G., Chang, R. L., Levin, W., Lu, A. Y. H., Yagi, H., Hernandez, O., Jerina, D. M., and Conney, A. H. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides. Cancer Res., 36: 3358–3366, 1976.
360. Yagi, H., Akagi, H., Thakker, D. R., Mah, H. D., Koreeda, M., and Jerina, D. M. Absolute stereochemistry of the highly mutagenic 7,8-diol 9,10-epoxides derived from the potent carcinogen frans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene. J. Am. Chem. Soc., 99: 2358–2359, 1977.
361. Yamamoto, R. S., Weisburger, J. H., and Weisburger, E. K. Controlling factors in urethan carcinogenesis in mice: effect of enzyme inducers and metabolic inhibitors. Cancer Res., 31: 483–486, 1971.
362. Yang, S. K. and Gelboin, H. V. Microsomal mixed-function oxidases and epoxide hydratase convert benzo(a]pyrene stereospecificalty to optically active dihydroxydihydrobenzo[a]pyrenes. Biochem. Pharmacol., 25: 2221–2225, 1976.
363. Yang, S. K., McCourt, D. W., Leutz, J. C., and Gelboin, H. V. Benzo[a]-pyrene diol epoxides: mechanism of enzymatic formation and optically active intermediates. Science (Wash. D. C.). 196: 1199-1201, 1977.
364. Yang, S. K., McCourt, D. W., Roller, P. P., and Gelboin, H. V. Enzymatic conversion of benzo[a]pyrene leading predominantly to the diol-epoxide r-7,f-8-dihydroxy-f-9,10-oxy-7,8,9,10-tetrahydrobenzo(aJpyrene through a single enantiomer of r-7,f-8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. U. S. A., 73: 2594–2598, 1976.
365. Yang, S. K., Roller, P. P., and Gelboin, H. V. Enzymatic mechanism of benzo[a]pyrene conversion to phenols and diols and an improved high-pressure liquid chromatographic separation of benzo(a]pyrene derivatives. Biochemistry, 16: 3680–3687, 1977.
366. Zampaglione, N., Jollow, D. J., Mitchell, J. R., Stripp, B., Hamrick, M., and Gillette, J. R. Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J. Pharmacol. Exp. Ther., 187: 218–227, 1973.